Navigation Links
012 Smile.Communications Reports Financial Results for Q4 and Full Year 2007
Date:2/26/2008

ember 31

2007 2006

(Unaudited)

NIS thousands

GAAP operating income 116,462 25,549

Adjustments

Amortization of acquired intangible assets 31,938 -

Non-recurring expenses 10,433 10,187

Non-GAAP adjusted operating income 158,833 35,736

GAAP tax expenses (benefit), net 23,462 10,315

Adjustments

Amortization of acquired intangible assets

included in tax expenses, net 9,262 -

Non-GAAP tax expenses (benefit), net 32,724 10,315

Net income (loss) as reported 40,957 (2,032)

Taxes on income 23,462 10,315

Non-recurring expenses 10,433 10,187

Financial expenses 52,043 17,266

Depreciation and amortization 110,243 11,297

Adjusted EBITDA 237,138 47,033

For further information, please contact:

Ms. Idit Azulay

012 Smile.Communications Ltd

+972-72-2003848

i.azulay@smile.net.il


'/>"/>
SOURCE 012 Smile.communications Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. 012 Smile.Communications to Deploy Extensive WiFi Internet Access System for Sheba Medical Center
2. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
3. Haemacure Reports Third Quarter 2007 Results
4. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
5. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
6. MDS Reports Third Quarter 2007 Results
7. Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006
8. AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
9. NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results
10. Blue Cross and Blue Shield of Florida Reports Eighteenth Consecutive Year of Positive Performance
11. ReBuilder Medical Technologies, Inc. Reports International Sales Expansion

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)...is & Ennis, P.A. is offering free nationwide c...min birth control pills who have suffered a Deep V...Heart Attack or other related cardiac issues or ha...ree at 1-800-856-6405 or go to the firm’s we... online case evaluation form. , ...
(Date:11/25/2009)...wire/-SentinelleMedicalInc.,aleadingmanufacturerof...chesasuiteofnewleadingedgeclinicalapplicationsonit...,sRadiologicalSocietyofNorthAmerica(RSNA)annualmee...heapplicationsleveragetheuniquehighqualityimagesge...supportmultipleimagingmodalitiesformulti-parametri...
(Date:11/25/2009)...ements,Business,andPressJoinEfforttoEducate ,,...again,theNationalBipolarFoundationandtheMedicAlert...tilStable"program,whichisnowbeingwidelyacceptedasa...y,theNationalBipolarFoundationreceivedaproclamatio...Lt.GovernorofLouisianaMitchLandrieu.TheNationalBip...
(Date:11/25/2009)...s too short to draw definite conclusions, experts ...News) -- In diabetic patients with blocked coronar...utcomes at one year whether patients undergo bypas...searchers report. , Bypass surgery has been the...onary artery disease. However, less invasive appro...
(Date:11/25/2009)...es few signs of trouble with the H1N1 vaccine, ,... The ongoing H1N1 swine flu pandemic may be drivin...nger patients, a U.S. health official said Wednesd...umococcal infections around the country," Dr. Anne...unization and Respiratory Diseases at the U.S. Cen...
Breaking Medicine News(10 mins):Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 3Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 3Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3Health News:Swine Flu Tied to Rise in Pneumonias Among Young 2Health News:Swine Flu Tied to Rise in Pneumonias Among Young 3Health News:Swine Flu Tied to Rise in Pneumonias Among Young 4
...ion, Training and Resources, WASHINGTON, Dec. 6 ...unced it will provide nearly $4.7 million,for "car...prove health care,education and provide needed tra...mily members,and other caregivers who sacrifice to...
...hua-PRNewswire-FirstCall/ -- China Shenghuo,Pharma...mpany") (Amex:,KUN), which is engaged in the resea...armaceutical, nutritional supplement and cosmetic ...s,12Ways(R) Chinese Herbal Cosmetics on China Cent...
...y might prevent cardiac arrest , , THURSDA...,re moving closer to using transplanted cells to p...n cardiac arrest. , Working with mice, scientists...-author Dr. Michael Kotlikoff, a professor in the ...
... First Half of 2008 -, SAN DIEGO and INDIANAPOLIS...MLN ) and Eli Lilly and Company (NYSE: LLY ),toda...monotherapy, or,stand-alone, BYETTA (exenatide) in...wed significant reductions in A1C (a,measure of av...
...oducts to Reach Sales of $1 Billion or More in ...ipeline Offers Promising Outlook; 6 Launches Expec... - R&D Investment and Productivity Gains plus Aggr...t Outcomes,- Lilly Reconfirms 2007 Sales and Earni...
...y, the nation,s leading,oncology services company,...xecutive vice president and chief operating office... 2008., "Glen,s Fortune 500 operating experience,...nt of US Oncology.,"His proven success in working ...
Other Medicine News:Health News:VA Announces $4.7 Million to Help Caregivers 2Health News:VA Announces $4.7 Million to Help Caregivers 3Health News:China Shenghuo Pharmaceutical Holdings, Inc. to Launch 12Ways(R) Advertisement on CCTV in January 2008 2Health News:China Shenghuo Pharmaceutical Holdings, Inc. to Launch 12Ways(R) Advertisement on CCTV in January 2008 3Health News:Cell Transplants Hold Promise for Heart Attack Survivors 2Health News:Monotherapy BYETTA(R) Showed Significant Improvement in Glucose Control and Weight Loss in Adults with Type 2 Diabetes 2Health News:Monotherapy BYETTA(R) Showed Significant Improvement in Glucose Control and Weight Loss in Adults with Type 2 Diabetes 3Health News:Monotherapy BYETTA(R) Showed Significant Improvement in Glucose Control and Weight Loss in Adults with Type 2 Diabetes 4Health News:Monotherapy BYETTA(R) Showed Significant Improvement in Glucose Control and Weight Loss in Adults with Type 2 Diabetes 5Health News:Monotherapy BYETTA(R) Showed Significant Improvement in Glucose Control and Weight Loss in Adults with Type 2 Diabetes 6Health News:Lilly Showcases Pipeline Opportunities to Wall Street, Sets 2008 Financial Guidance and Outlines Transformation Strategy 2Health News:Lilly Showcases Pipeline Opportunities to Wall Street, Sets 2008 Financial Guidance and Outlines Transformation Strategy 3Health News:Lilly Showcases Pipeline Opportunities to Wall Street, Sets 2008 Financial Guidance and Outlines Transformation Strategy 4Health News:Lilly Showcases Pipeline Opportunities to Wall Street, Sets 2008 Financial Guidance and Outlines Transformation Strategy 5Health News:Lilly Showcases Pipeline Opportunities to Wall Street, Sets 2008 Financial Guidance and Outlines Transformation Strategy 6Health News:Lilly Showcases Pipeline Opportunities to Wall Street, Sets 2008 Financial Guidance and Outlines Transformation Strategy 7Health News:Lilly Showcases Pipeline Opportunities to Wall Street, Sets 2008 Financial Guidance and Outlines Transformation Strategy 8Health News:Lilly Showcases Pipeline Opportunities to Wall Street, Sets 2008 Financial Guidance and Outlines Transformation Strategy 9Health News:Lilly Showcases Pipeline Opportunities to Wall Street, Sets 2008 Financial Guidance and Outlines Transformation Strategy 10Health News:Lilly Showcases Pipeline Opportunities to Wall Street, Sets 2008 Financial Guidance and Outlines Transformation Strategy 11Health News:Lilly Showcases Pipeline Opportunities to Wall Street, Sets 2008 Financial Guidance and Outlines Transformation Strategy 12Health News:Lilly Showcases Pipeline Opportunities to Wall Street, Sets 2008 Financial Guidance and Outlines Transformation Strategy 13Health News:Lilly Showcases Pipeline Opportunities to Wall Street, Sets 2008 Financial Guidance and Outlines Transformation Strategy 14Health News:US Oncology Appoints Glen Laschober EVP & Chief Operating Officer 2
(Date:11/25/2009)...FirstCall/--Abaxis,Inc.(Nasdaq: ABAX ),amedicalpro...ssystems,announcedtodaythatClintSeverson,chairmana...PiperJaffrayHealthCareConferenceonWednesday,Decemb...ewYorkPalaceHotelinNewYorkCity. ,, AboutAbaxis...blebloodanalysissystemsforuseinanyveterinaryorhuma...
(Date:11/25/2009)...-CempraPharmaceuticalsInc.todayannouncedthatPrabha...illpresentatthePiperJaffray21stAnnualHealthCareCon...laceHotelinNewYorkCity.Dr.Fernandeswillprovideanov...ogramsforthetreatmentofdrug-resistantpathogensincl..., Foundedin2006,CempraPharmaceuticalsisaprivately-...
(Date:11/25/2009)...Newswire-FirstCall/--HeartWareInternational,Inc.(N...oflessinvasive,miniaturizedcirculatorysupporttechn...ailure,todayannouncedthatitisscheduledtomakeaninve...areConferenceat8:00amESTonWednesday,December2,2009...ecember1-2. ,, AlivewebcastoftheCompany,spresen...
Breaking Medicine Technology:Vion Pharmaceuticals Announces Results of the Oncologic Drugs Advisory Committee Meeting for Onrigin 28TM 29 4936 1Vion Pharmaceuticals Announces Results of the Oncologic Drugs Advisory Committee Meeting for Onrigin 28TM 29 4936 2Vion Pharmaceuticals Announces Results of the Oncologic Drugs Advisory Committee Meeting for Onrigin 28TM 29 4936 3New Technique Offers Hope for Kids With Immune Deficiency 55986 1New Technique Offers Hope for Kids With Immune Deficiency 55986 2PTC Therapeutics Announces Celgene Exercised Option to Drug Discovery Collaboration 13793 1PTC Therapeutics Announces Celgene Exercised Option to Drug Discovery Collaboration 13793 2
...t Lymphoma Meeting in Lugano, Switzerland, SOUTH ...d an abstract providing preliminary results of a P...788 (fostamatinib disodium), in,patients with rela...(NHL).,The abstract reports favorable responses fo...ma/chronic lymphocytic leukemia (SLL/CLL) or from ...
...f., June 2 Rigel,Pharmaceuticals, Inc. (Nasdaq: ...nce call with simultaneous webcast to discuss the ...of R788, a novel, oral Syk kinase,inhibitor, in pa...day, June,3, 2008 at 8:00 a.m. EDT. Participating ...e principal investigator on the study, Jonathan Fr...
Other Medicine Technology:Preliminary Phase 2 Results of R788 in Lymphoma Show Benefit in Diffuse Large B-Cell and SLL/CLL 2Preliminary Phase 2 Results of R788 in Lymphoma Show Benefit in Diffuse Large B-Cell and SLL/CLL 3Preliminary Phase 2 Results of R788 in Lymphoma Show Benefit in Diffuse Large B-Cell and SLL/CLL 4Rigel to Host Conference Call to Discuss Preliminary Phase 2 Study Results of R788 in Lymphoma 2
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
Medicine Products: